Goddard Glenn

EDGAR CIK 0001581992

Intellia Therapeutics, Inc. - NTLA

  1. Manufacturing
  2. Chemicals
  3. In Vitro & In Vivo Diagnostic Substances
CFO
EVP, Chief Financial Officer
Direct Buys
0
$0
0 Shares
Direct Sells
1
($158,053)
-5,365 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
01/03/2024
01/05/2024
Sell
-5,365 @ $29.46
 ($158,053) 40,585 (-11.68%) Direct